Antibody titers reactive with Rickettsia rickettsii in blood donors and implications for surveillance of spotted fever rickettsiosis in the United States.
Since 2000, the reported prevalence of tick-borne spotted fever group rickettsioses (SFGR) has increased considerably. We compared the level of antibody reactivity among healthy blood donors from two widely separated regions of the United States, and evaluated the impact of antibody prevalence on public health surveillance in one of these regions. Donor serum samples were evaluated by indirect immunofluorescence antibody assay to identify immunoglobulin G antibodies reactive with Rickettsiarickettsii. The Georgia Department of Public Health (GDPH) analyzed characteristics of cases from 2016 surveillance data to evaluate the utility of laboratory surveillance for case assessment. Of the Georgia donors (N = 1,493), 11.1% demonstrated antibody titers reactive with R. rickettsii at titers ≥ 64, whereas 6.3% of donors from Oregon and Washington (N =1,511) were seropositive. Most seropositive donors had a titer of 64; only 3.1% (N = 93) of all donors had titers ≥ 128. During 2016, GDPH interviewed 243 seropositive case-patients; only 28% (N = 69) met criteria defined in the national SFGR case definition. These findings suggest that a single IgG antibody titer is an unreliable measure of diagnosis and could inaccurately affect surveillance estimates that define magnitude and clinical characteristics of SFGR.